Avedro

Waltham, United States Founded: 2007 • Age: 19 yrs Acquired By Glaukos
Corneal collagen cross-linking technology is developed for ophthalmic applications.
Request Access

About Avedro

Avedro is a company based in Waltham (United States) founded in 2007 was acquired by Glaukos in August 2019.. Avedro has raised $210.76 million across 11 funding rounds from investors including Glaukos, Flagship Pioneering and Orbimed. The company has 113 employees as of December 31, 2022. Avedro operates in a competitive market with competitors including CorneaGen, EyeGate, Cellusion, EyeYon and CorNeat Vision, among others.

  • Headquarter Waltham, United States
  • Employees 113 as on 31 Dec, 2022
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Avedro, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $210.76 M (USD)

    in 11 rounds

  • Latest Funding Round
    $25 M (USD), Series E

    May 02, 2018

  • Investors
    Glaukos

    & 13 more

  • Employee Count
    113

    as on Dec 31, 2022

  • Acquired by
    Glaukos

    (Aug 07, 2019)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Avedro

Avedro has successfully raised a total of $210.76M across 11 strategic funding rounds. The most recent funding activity was a Series E round of $25 million completed in May 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 11
  • Last Round Series E — $25.0M
  • First Round

    (29 Apr 2009)

  • Investors Count 13
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2018 Amount Series E - Avedro Valuation Lilly Asia Ventures
Apr, 2017 Amount Series E - Avedro Valuation Health Quest Capital
Apr, 2017 Amount Debt – Conventional - Avedro Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Avedro

Avedro has secured backing from 14 investors, including institutional and venture fund investors. Prominent investors backing the company include Glaukos, Flagship Pioneering and Orbimed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
Founded Year Domain Location
Early-stage investing in IT and healthcare ventures.
Founded Year Domain Location
Investments are focused on tech and life sciences startups.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Avedro

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Avedro

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Avedro Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Avedro

Avedro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CorneaGen, EyeGate, Cellusion, EyeYon and CorNeat Vision, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapeutic devices for corneal transplants are developed by CorneaGen.
domain founded_year HQ Location
Therapeutics and drug delivery systems for eye diseases are developed.
domain founded_year HQ Location
iPS cell-based technology for corneal endothelium regeneration is developed.
domain founded_year HQ Location
Ophthalmic devices for corneal edema treatment are developed.
domain founded_year HQ Location
Nanotechnology-based artificial corneal implants are developed for ophthalmic use.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Avedro

When was Avedro founded?

Avedro was founded in 2007 and raised its 1st funding round 2 years after it was founded.

Where is Avedro located?

Avedro is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.

Is Avedro a funded company?

Avedro is a funded company, having raised a total of $210.76M across 11 funding rounds to date.

How many employees does Avedro have?

As of Dec 31, 2022, the latest employee count at Avedro is 113.

What does Avedro do?

Developer of corneal collagen cross-linking technology. Its products, the VibeX and KXL System for performing Lasik Xtra and accelerated cross-linking have been commercialized outside the US. It also received approval from the China FDA for its KXL system in Nov 2015.

Who are the top competitors of Avedro?

Avedro's top competitors include CorneaGen, EyeYon and EyeGate.

Who are Avedro's investors?

Avedro has 14 investors. Key investors include Glaukos, Flagship Pioneering, Orbimed, Abingworth, and Lilly Asia Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available